Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

RYGklinikken ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5%   Bankruptcy risk   14.1% 11.3% 15.1% 11.7% 13.5% 11.2% 18.4% 18.4%   Credit score (0-100)   16 23 13 19 16 20 8 8   Credit rating   BB BB BB BB BB BB B B   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   736 654 811 1,323 1,531 1,537 0.0 0.0   EBITDA   396 96.4 32.3 332 192 162 0.0 0.0   EBIT   359 58.9 5.3 311 189 162 0.0 0.0   Pre-tax profit (PTP)   354.5 54.6 4.5 309.8 181.9 161.2 0.0 0.0   Net earnings   275.0 39.7 3.2 241.1 139.0 125.6 0.0 0.0   Pre-tax profit without non-rec. items   354 54.6 4.5 310 182 161 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   41.1 19.6 8.6 3.7 0.0 0.0 0.0 0.0   Shareholders equity total   326 115 58.4 300 189 176 0.0 0.0   Interest-bearing liabilities   109 100 10.0 30.8 45.0 76.9 0.0 0.0   Balance sheet total (assets)   567 478 487 618 421 436 0.0 0.0   Net Debt   -357 -300 -383 -453 -225 -292 0.0 0.0     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   736 654 811 1,323 1,531 1,537 0.0 0.0   Gross profit growth   146.7% -11.1% 24.0% 63.2% 15.7% 0.4% -100.0% 0.0%   Employees   0 0 0 0 0 2 0 0   Employee growth %   -100.0% 0.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 -778.8 -991.8 -1,338.5 -1,375.1 0.0 0.0   Balance sheet total (assets)   567 478 487 618 421 436 0 0   Balance sheet change%   73.2% -15.6% 1.8% 26.9% -31.9% 3.8% -100.0% 0.0%   Added value   396.4 96.4 811.1 1,323.4 1,548.0 1,537.3 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -75 -75 -54 -42 -7 0 0 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   2.0 3.0 4.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   48.8% 9.0% 0.7% 23.5% 12.3% 10.6% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   80.3% 11.3% 1.1% 57.0% 36.3% 38.2% 0.0% 0.0%   ROI %   103.3% 17.7% 3.6% 156.7% 66.7% 67.2% 0.0% 0.0%   ROE %   112.2% 18.0% 3.7% 134.7% 56.9% 68.9% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   57.5% 24.1% 12.0% 48.5% 44.9% 40.2% 0.0% 0.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -90.2% -310.9% -1,186.2% -136.5% -116.8% -180.1% 0.0% 0.0%   Gearing %   33.5% 86.7% 17.1% 10.3% 23.8% 43.8% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   4.9% 4.1% 1.5% 24.0% 17.5% 3.8% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   2.1 1.2 1.1 1.9 1.8 1.7 0.0 0.0   Current Ratio   2.1 1.2 1.1 1.9 1.8 1.7 0.0 0.0   Cash and cash equivalent   466.4 399.6 393.1 483.5 269.6 369.0 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   246.5 63.5 30.0 290.9 183.2 169.7 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 0 0 0 0 769 0 0   Employee expenses / employee   0 0 0 0 0 -688 0 0   EBITDA / employee   0 0 0 0 0 81 0 0   EBIT / employee   0 0 0 0 0 81 0 0   Net earnings / employee   0 0 0 0 0 63 0 0